IL140422A0 - Retinoid-related receptor function regulating agent - Google Patents
Retinoid-related receptor function regulating agentInfo
- Publication number
- IL140422A0 IL140422A0 IL14042299A IL14042299A IL140422A0 IL 140422 A0 IL140422 A0 IL 140422A0 IL 14042299 A IL14042299 A IL 14042299A IL 14042299 A IL14042299 A IL 14042299A IL 140422 A0 IL140422 A0 IL 140422A0
- Authority
- IL
- Israel
- Prior art keywords
- retinoid
- receptor function
- regulating agent
- function regulating
- related receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18669898 | 1998-07-01 | ||
| PCT/JP1999/003520 WO2000001679A1 (fr) | 1998-07-01 | 1999-06-30 | Regulateurs du recepteur associe aux retinoides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL140422A0 true IL140422A0 (en) | 2002-02-10 |
Family
ID=16193077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14042299A IL140422A0 (en) | 1998-07-01 | 1999-06-30 | Retinoid-related receptor function regulating agent |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6545009B1 (id) |
| EP (1) | EP1092711A4 (id) |
| KR (1) | KR20010053282A (id) |
| CN (1) | CN1314899A (id) |
| AU (1) | AU4394799A (id) |
| BR (1) | BR9911752A (id) |
| CA (1) | CA2332178A1 (id) |
| HU (1) | HUP0102470A3 (id) |
| ID (1) | ID29247A (id) |
| IL (1) | IL140422A0 (id) |
| LV (1) | LV12633B (id) |
| NO (1) | NO20006667L (id) |
| PL (1) | PL345247A1 (id) |
| SK (1) | SK20182000A3 (id) |
| WO (1) | WO2000001679A1 (id) |
| ZA (1) | ZA200007635B (id) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548529B1 (en) | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| US7241785B2 (en) | 2001-03-23 | 2007-07-10 | Takeda Pharmaceutical Company Limited | Five-membered heterocyclic alkanoic acid derivative |
| MXPA03009562A (es) * | 2001-04-18 | 2004-02-12 | Genzyme Corp | METODO PARA TRATAR EL SiNDROME X CON POLIAMINAS ALIFATICAS. |
| GB0112348D0 (en) * | 2001-05-19 | 2001-07-11 | Smithkline Beecham Plc | Compounds |
| WO2003000301A1 (en) * | 2001-06-22 | 2003-01-03 | Merck & Co., Inc. | Combination of a ppar-alpha ligand and glucocorticoid for the treatment or prevention of inflammation |
| JP2003081832A (ja) * | 2001-06-26 | 2003-03-19 | Takeda Chem Ind Ltd | レチノイド関連受容体機能調節剤 |
| WO2003000249A1 (fr) * | 2001-06-26 | 2003-01-03 | Takeda Chemical Industries, Ltd. | Regulateur de la fonction du recepteur relatif aux retinoides |
| DE60217918T2 (de) * | 2001-12-29 | 2007-11-15 | Novo Nordisk A/S | Kombinierte verwendung einer glp-1-verbindung und eines aldose reduktase inhibitors |
| AU2003211385A1 (en) | 2002-02-28 | 2003-09-09 | Takeda Chemical Industries, Ltd. | Azole compounds |
| ZA200503967B (en) | 2002-11-01 | 2006-11-29 | Takeda Pharmaceutical | Agent for preventing or treating neuropathy |
| GB0303503D0 (en) * | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
| DE10308353A1 (de) * | 2003-02-27 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| CA2599281C (en) * | 2005-02-25 | 2012-01-17 | Heonjoong Kang | Thiazole derivatives as ppar delta ligands and their manufacturing process |
| KR100797798B1 (ko) * | 2005-02-25 | 2008-01-24 | 재단법인서울대학교산학협력재단 | 퍼록시솜 증식자 활성화 수용체 델타 리간드 티아졸 유도체및 그의 제조방법 |
| KR20080066938A (ko) * | 2005-10-07 | 2008-07-17 | 깃세이 야쿠힌 고교 가부시키가이샤 | 질소 함유 복소환 화합물 및 그것을 함유하는 의약 조성물 |
| WO2008064136A2 (en) * | 2006-11-17 | 2008-05-29 | Acadia Pharmaceuticals Inc. | Compounds with activity at retinoic acid receptors |
| US9187485B2 (en) | 2007-02-02 | 2015-11-17 | Baylor College Of Medicine | Methods and compositions for the treatment of cancer and related hyperproliferative disorders |
| CN101674730B (zh) | 2007-02-02 | 2014-09-10 | 贝勒医学院 | 用于治疗代谢疾病的组合物和方法 |
| US9085566B2 (en) | 2007-02-02 | 2015-07-21 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic and related disorders |
| US9212179B2 (en) | 2007-02-02 | 2015-12-15 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic disorders |
| US9233941B2 (en) | 2007-02-02 | 2016-01-12 | Baylor College Of Medicine | Methods and compositions for the treatment of body weight related disorders |
| EP2947080B1 (en) | 2007-08-13 | 2017-10-25 | Monsanto Technology LLC | Compositions and methods for controlling nematodes |
| WO2011011105A2 (en) * | 2009-05-07 | 2011-01-27 | Baylor College Of Medicine | Traceable retinoid acid for imaging, disease prevention and therapy |
| GB0915196D0 (en) | 2009-09-01 | 2009-10-07 | King S College London | Therapeutic compounds and their use |
| WO2012028100A1 (en) * | 2010-09-01 | 2012-03-08 | Glaxo Group Limited | Novel compounds |
| JP6797800B2 (ja) * | 2014-12-19 | 2020-12-09 | ガルデルマ・リサーチ・アンド・デヴェロップメント | 新規化合物、その合成方法、並びに医薬品及び化粧品におけるその使用 |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
| US10865793B2 (en) | 2016-12-06 | 2020-12-15 | Air Squared, Inc. | Scroll type device having liquid cooling through idler shafts |
| US20200025199A1 (en) | 2018-07-17 | 2020-01-23 | Air Squared, Inc. | Dual drive co-rotating spinning scroll compressor or expander |
| US11530703B2 (en) | 2018-07-18 | 2022-12-20 | Air Squared, Inc. | Orbiting scroll device lubrication |
| US11473572B2 (en) | 2019-06-25 | 2022-10-18 | Air Squared, Inc. | Aftercooler for cooling compressed working fluid |
| US11898557B2 (en) | 2020-11-30 | 2024-02-13 | Air Squared, Inc. | Liquid cooling of a scroll type compressor with liquid supply through the crankshaft |
| US11885328B2 (en) | 2021-07-19 | 2024-01-30 | Air Squared, Inc. | Scroll device with an integrated cooling loop |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001420A (en) | 1968-12-12 | 1977-01-04 | Science Union Et Cie, Societe Francaise De Recherche Medical | Thiazolyl benzoic acid compounds |
| GB1308028A (en) | 1970-06-12 | 1973-02-21 | Science Union & Cie | Thiazolylbenzoic acid derivatives and a process for their manufactur |
| JPS4932853A (id) | 1972-07-27 | 1974-03-26 | ||
| US4043973A (en) | 1974-10-02 | 1977-08-23 | Eastman Kodak Company | Multichromophoric ultraviolet stabilizers for organic compositions |
| US3939115A (en) | 1974-10-02 | 1976-02-17 | Eastman Kodak Company | Polychromophoric ultraviolet stabilizers and their use in organic compositions |
| US4164480A (en) | 1978-01-09 | 1979-08-14 | Eastman Kodak Company | Polychromophoric ultraviolet stabilizers and their use in organic compositions |
| SU1078859A1 (ru) | 1982-03-31 | 1997-10-20 | Б.М. Красовицкий | 2-(5-фенилоксазолил-2)-5-(5-арилоксазолил-2)-бензойные кислоты в качестве органических люминофоров сине-зеленого свечения в органических растворителях и водной среде |
| JPH0725754B2 (ja) | 1986-01-30 | 1995-03-22 | 富山化学工業株式会社 | 新規なチアゾール化合物またはその塩 |
| JP2524786B2 (ja) | 1987-12-15 | 1996-08-14 | コニカ株式会社 | 直接ポジハロゲン化銀カラ―写真感光材料 |
| DE3903993A1 (de) | 1989-02-10 | 1990-08-16 | Basf Ag | Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus |
| JP2941937B2 (ja) | 1990-01-25 | 1999-08-30 | キヤノン株式会社 | 新規化合物、これを含む液晶組成物及びこれを使用した液晶素子並びに表示装置 |
| JPH04154773A (ja) * | 1990-10-15 | 1992-05-27 | Green Cross Corp:The | チアゾール誘導体 |
| ES2245660T3 (es) | 1990-11-30 | 2006-01-16 | Otsuka Pharmaceutical Co., Ltd. | Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos. |
| US5639770A (en) | 1992-05-29 | 1997-06-17 | Otsuka Pharmaceutical Co., Ltd. | Thiazole derivatives |
| JP3385387B2 (ja) | 1992-05-29 | 2003-03-10 | 大塚製薬株式会社 | チアゾール誘導体 |
| US5342851A (en) | 1992-10-07 | 1994-08-30 | Mcneil-Ppc, Inc. | Substituted thiazole derivatives useful as platelet aggregation inhibitors |
| DE4302051A1 (de) | 1993-01-26 | 1994-07-28 | Thomae Gmbh Dr K | 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| KR19980702466A (ko) | 1995-02-24 | 1998-07-15 | 페라 스타르크, 요헨 카르크 | 피라졸-4-일-벤조일 유도체 및 제초제로서의 그의 용도 |
| JP3964478B2 (ja) | 1995-06-30 | 2007-08-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬 |
| JP3865829B2 (ja) * | 1995-09-21 | 2007-01-10 | 株式会社医薬分子設計研究所 | レチノイド作用増強性化合物 |
| ES2124167B1 (es) | 1996-06-04 | 1999-09-16 | Espanola Prod Quimicos | Nuevos derivados del bencimidazol con actividad antihistaminica. |
| AU4015497A (en) * | 1996-08-26 | 1998-03-19 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Thiazole derivatives useful as selective inhibitors of pde-iv |
| JP4300373B2 (ja) | 1996-09-30 | 2009-07-22 | 大塚製薬株式会社 | サイトカイン産生抑制剤及び接着抑制剤 |
| AUPO691897A0 (en) | 1997-05-21 | 1997-06-12 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
-
1999
- 1999-06-30 WO PCT/JP1999/003520 patent/WO2000001679A1/ja not_active Application Discontinuation
- 1999-06-30 SK SK2018-2000A patent/SK20182000A3/sk unknown
- 1999-06-30 CN CN99810103A patent/CN1314899A/zh active Pending
- 1999-06-30 KR KR1020007014995A patent/KR20010053282A/ko not_active Application Discontinuation
- 1999-06-30 EP EP99926853A patent/EP1092711A4/en not_active Withdrawn
- 1999-06-30 HU HU0102470A patent/HUP0102470A3/hu unknown
- 1999-06-30 PL PL99345247A patent/PL345247A1/xx not_active Application Discontinuation
- 1999-06-30 ID IDW20010004D patent/ID29247A/id unknown
- 1999-06-30 IL IL14042299A patent/IL140422A0/xx unknown
- 1999-06-30 CA CA002332178A patent/CA2332178A1/en not_active Abandoned
- 1999-06-30 AU AU43947/99A patent/AU4394799A/en not_active Abandoned
- 1999-06-30 BR BR9911752-5A patent/BR9911752A/pt not_active Application Discontinuation
- 1999-06-30 US US09/720,644 patent/US6545009B1/en not_active Expired - Fee Related
-
2000
- 2000-12-19 ZA ZA200007635A patent/ZA200007635B/en unknown
- 2000-12-27 NO NO20006667A patent/NO20006667L/no not_active Application Discontinuation
- 2000-12-28 LV LVP-00-177A patent/LV12633B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1092711A4 (en) | 2002-07-31 |
| CN1314899A (zh) | 2001-09-26 |
| ID29247A (id) | 2001-08-16 |
| HUP0102470A3 (en) | 2002-05-28 |
| SK20182000A3 (sk) | 2001-08-06 |
| NO20006667L (no) | 2001-02-28 |
| LV12633A (lv) | 2001-03-20 |
| PL345247A1 (en) | 2001-12-03 |
| EP1092711A1 (en) | 2001-04-18 |
| LV12633B (en) | 2001-07-20 |
| KR20010053282A (ko) | 2001-06-25 |
| US6545009B1 (en) | 2003-04-08 |
| NO20006667D0 (no) | 2000-12-27 |
| CA2332178A1 (en) | 2000-01-13 |
| WO2000001679A1 (fr) | 2000-01-13 |
| ZA200007635B (en) | 2002-01-02 |
| BR9911752A (pt) | 2001-04-03 |
| AU4394799A (en) | 2000-01-24 |
| HUP0102470A2 (hu) | 2002-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL140422A0 (en) | Retinoid-related receptor function regulating agent | |
| IL134108A0 (en) | Substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
| IL139241A0 (en) | Meiosis regulating compounds | |
| ZA986360B (en) | Tricyclically substituted oxazolidinones | |
| EP0965321A4 (en) | COMPOSITION FOR EXTERNAL USE | |
| AU6209098A (en) | Herbicidal agent | |
| AU7132898A (en) | Edg-1-like receptor | |
| AU9770498A (en) | Regulator | |
| AU1744700A (en) | Human neurotensin subtype 2 receptor | |
| AU1631799A (en) | Fungicidal amides | |
| EP1084142A4 (en) | GPR35A RECEIVER | |
| GB9725055D0 (en) | 1,3,4-thiadiazoles compounds | |
| GB9819420D0 (en) | Novel receptor | |
| AU6620498A (en) | Herbicidal agent | |
| IL134408A0 (en) | Anti-first- pass effect compounds | |
| GB2341222B (en) | Adjusting unit | |
| EP1083909A4 (en) | hCEPR RECEPTOR | |
| IL140216A0 (en) | Meiosis regulating compounds | |
| GB9717321D0 (en) | Herbicidal composition | |
| GB9704082D0 (en) | Bathwater regulator | |
| GB2314014B (en) | Closure-arrangements for loose-covers | |
| EP1109565A4 (en) | GABAB1AA RECEPTOR | |
| AU6263699A (en) | Response regulator (cassk1) | |
| ZA988780B (en) | Regulating device | |
| TW365172U (en) | Catheder application strap |